245 related articles for article (PubMed ID: 30010299)
41. Everolimus in infants with tuberous sclerosis complex-related West syndrome: First results from a single-center prospective observational study.
Samueli S; Dressler A; Gröppel G; Scholl T; Feucht M
Epilepsia; 2018 Sep; 59(9):e142-e146. PubMed ID: 30098008
[TBL] [Abstract][Full Text] [Related]
42. Potential of mTOR inhibitors for the treatment of subependymal giant cell astrocytomas in tuberous sclerosis complex.
Major P
Aging (Albany NY); 2011 Mar; 3(3):189-91. PubMed ID: 21415462
[TBL] [Abstract][Full Text] [Related]
43. Safety of Everolimus in Patients Younger than 3 Years of Age: Results from EXIST-1, a Randomized, Controlled Clinical Trial.
Jóźwiak S; Kotulska K; Berkowitz N; Brechenmacher T; Franz DN
J Pediatr; 2016 May; 172():151-155.e1. PubMed ID: 26858193
[TBL] [Abstract][Full Text] [Related]
44. Direct medical costs for patients with tuberous sclerosis complex and surgical resection of subependymal giant cell astrocytoma: a US national cohort study.
Sun P; Liu Z; Krueger D; Kohrman M
J Med Econ; 2015 May; 18(5):349-56. PubMed ID: 25525770
[TBL] [Abstract][Full Text] [Related]
45. Subependymal giant cell astrocytoma in the absence of tuberous sclerosis complex: case report.
Beaumont TL; Godzik J; Dahiya S; Smyth MD
J Neurosurg Pediatr; 2015 Aug; 16(2):134-7. PubMed ID: 25978531
[TBL] [Abstract][Full Text] [Related]
46. Factors affecting response to everolimus therapy for subependymal giant cell astrocytomas associated with tuberous sclerosis.
Trelinska J; Dachowska I; Kotulska K; Baranska D; Fendler W; Jozwiak S; Mlynarski W
Pediatr Blood Cancer; 2015 Apr; 62(4):616-21. PubMed ID: 25557360
[TBL] [Abstract][Full Text] [Related]
47. Tuber Brain Proportion Determines Epilepsy Onset in Children With Tuberous Sclerosis Complex.
Zhang F; Xie L; He X; Song X; Zheng H; Wang L; Jiang L
Pediatr Neurol; 2022 Apr; 129():39-45. PubMed ID: 35217276
[TBL] [Abstract][Full Text] [Related]
48. A case of subependymal giant cell astrocytoma without tuberous sclerosis complex and review of the literature.
O'Rawe M; Chandran AS; Joshi S; Simonin A; Dyke JM; Lee S
Childs Nerv Syst; 2021 Apr; 37(4):1381-1385. PubMed ID: 32808065
[TBL] [Abstract][Full Text] [Related]
49. Everolimus (RAD001): first systemic treatment for subependymal giant cell astrocytoma associated with tuberous sclerosis complex.
Józwiak S; Stein K; Kotulska K
Future Oncol; 2012 Dec; 8(12):1515-23. PubMed ID: 23231513
[TBL] [Abstract][Full Text] [Related]
50. Current Use of mTOR Inhibitors for the Treatment of Subependymal Giant Cell Astrocytomas and Epilepsy in Patients with TSC.
Jancic J; Duric V; Ivancevic N; Nikolic B; van den Anker JN; Samardzic J
Curr Med Chem; 2016; 23(37):4260-4269. PubMed ID: 27739368
[TBL] [Abstract][Full Text] [Related]
51. Isolated cortical tuber in an infant with genetically confirmed tuberous sclerosis complex 1 presenting with symptomatic West syndrome.
Miyata H; Fushimi S; Ota Y; Vinters HV; Adachi K; Nanba E; Akiyama T
Neuropathology; 2021 Feb; 41(1):58-64. PubMed ID: 33181865
[TBL] [Abstract][Full Text] [Related]
52. Regression of subependymal giant cell astrocytomas with RAD001 (Everolimus) in tuberous sclerosis complex.
Yalon M; Ben-Sira L; Constantini S; Toren A
Childs Nerv Syst; 2011 Jan; 27(1):179-81. PubMed ID: 20703486
[TBL] [Abstract][Full Text] [Related]
53. Natural History and Current Treatment Options for Subependymal Giant Cell Astrocytoma in Tuberous Sclerosis Complex.
Jóźwiak S; Mandera M; Młynarski W
Semin Pediatr Neurol; 2015 Dec; 22(4):274-81. PubMed ID: 26706014
[TBL] [Abstract][Full Text] [Related]
54. [Effectiveness of vigabatrin in west syndrome associated with tuberous sclerosis].
Ando N; Fujimoto S; Ishikawa T; Kobayashi S; Hattori A; Ito T; Togari H
No To Hattatsu; 2010 Nov; 42(6):444-8. PubMed ID: 21077355
[TBL] [Abstract][Full Text] [Related]
55. Use of the mTOR inhibitor everolimus in a patient with multiple manifestations of tuberous sclerosis complex including epilepsy.
Wheless JW
Epilepsy Behav Case Rep; 2015; 4():63-6. PubMed ID: 26543807
[TBL] [Abstract][Full Text] [Related]
56. Subependymal giant cell astrocytomas in patients with tuberous sclerosis complex: considerations for surgical or pharmacotherapeutic intervention.
Wheless JW; Klimo P
J Child Neurol; 2014 Nov; 29(11):1562-71. PubMed ID: 24105488
[TBL] [Abstract][Full Text] [Related]
57. Surgical treatment of subependymal giant cell astrocytoma in tuberous sclerosis complex patients.
Kotulska K; Borkowska J; Roszkowski M; Mandera M; Daszkiewicz P; Drabik K; Jurkiewicz E; Larysz-Brysz M; Nowak K; Grajkowska W; Domańska-Pakieła D; Jóźwiak S
Pediatr Neurol; 2014 Apr; 50(4):307-12. PubMed ID: 24507694
[TBL] [Abstract][Full Text] [Related]
58. [The Efficacy of Everolimus for Refractory Seizures in Childhood Onset Epilepsy with Tuberous Sclerosis Complex].
Okanishi T; Fujimoto A; Nishimura M; Baba S; Itamura S; Okanari K; Enoki H
Brain Nerve; 2019 Jun; 71(6):611-616. PubMed ID: 31171758
[TBL] [Abstract][Full Text] [Related]
59. Pathological Findings of a Subependymal Giant Cell Astrocytoma Following Treatment With Rapamycin.
Cheng S; Hawkins C; Taylor MD; Bartels U
Pediatr Neurol; 2015 Sep; 53(3):238-242.e1. PubMed ID: 26173783
[TBL] [Abstract][Full Text] [Related]
60. The level of microRNA 21 is upregulated by rapamycin in serum of tuberous sclerosis complex patients and subependymal giant cell astrocytoma (SEGA)-derived cell cultures.
Kuzniewska B; Sadowski K; Urbanska K; Urbanska M; Kotulska K; Liszewska E; Grajkowska W; Jóźwiak S; Dziembowska M
Folia Neuropathol; 2018; 56(3):167-174. PubMed ID: 30509037
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]